Treatment with catheter ablation for patients with arrhythmia-induced cardiomyopathy caused by atrial fibrillation promises a good prognosis

Treatment with catheter ablation for patients with arrhythmia-induced cardiomyopathy caused by atrial fibrillation promises a good prognosis

Clinical outcomes after catheter ablation in patients with reduced left ventricular (LV) ejection fraction (EF) and atrial fibrillation (AF) remain unclear. This study aimed to explore the clinical outcomes of patients with arrhythmia-induced cardiomyopathy (AIC) and the influence of pharmacological...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart and vessels 2024-03, Vol.39 (3), p.240-251
Hauptverfasser: Aoyama, Daisetsu, Miyazaki, Shinsuke, Amaya, Naoki, Tama, Naoto, Hasegawa, Kanae, Nomura, Ryohei, Tsuji, Toshihiko, Nakano, Akira, Uzui, Hiroyasu, Tada, Hiroshi
Format: Artikel
Sprache:eng
Schlagworte:
Ablation
Angiotensin
Arrhythmia
Atrial Fibrillation - complications
Atrial Fibrillation - diagnosis
Atrial Fibrillation - surgery
Biomedical Engineering and Bioengineering
Cardiac arrhythmia
Cardiac Surgery
Cardiology
Cardiomyopathies - complications
Cardiomyopathies - diagnosis
Cardiomyopathy
Catheter Ablation - adverse effects
Catheter Ablation - methods
Catheters
Clinical outcomes
Congestive heart failure
Drug therapy
Fibrillation
Heart Failure
Humans
Inhibitors
Male
Medical instruments
Medicine
Medicine & Public Health
Multivariate analysis
Original Article
Patients
Prognosis
Radiofrequency ablation
Renin
Research ethics
Stroke Volume
Treatment Outcome
UMIN
UMIN000050391
Vascular Surgery
Ventricle
Ventricular Dysfunction, Left - etiology
Ventricular Function, Left
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Clinical outcomes after catheter ablation in patients with reduced left ventricular (LV) ejection fraction (EF) and atrial fibrillation (AF) remain unclear. This study aimed to explore the clinical outcomes of patients with arrhythmia-induced cardiomyopathy (AIC) and the influence of pharmacological treatment on clinical outcomes in patients with AIC after the procedure. Ninety-six patients with AF with a reduced LVEF (LVEF 
ISSN:0910-8327
1615-2573
DOI:10.1007/s00380-023-02329-7